offering

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: CytomX Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) --…

4 weeks ago

Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

March 12, 2026 20:30 ET  | Source: Indivior Pharmaceuticals Inc. RICHMOND, Va., March 12, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals,…

1 month ago

AIM ImmunoTech Announces Closing of its Rights Offering

OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or…

1 month ago

ION enhances Indian market offering with BSE equity derivatives empanelment

MUMBAI, India, Feb. 26, 2026 /PRNewswire/ -- ION, a global leader in trading and workflow automation software, high-value analytics and insights,…

2 months ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

2 months ago

Candel Therapeutics Announces Proposed $100 Million Public Offering

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical…

2 months ago

KIAASA Retail Limited’s Initial Public Offering to open on Monday, February 23, 2026, price band set at Rs 121 – Rs 127 per Equity Share

Price band of Rs 121– Rs 127 per Equity Share bearing face value of Rs 10 each ("Equity Shares")Bid/Offer Opening Date…

2 months ago

HTX and AINFT Collaborate to Build New Web3 AI Gateway, Offering Free Access to Leading AI Models and 40,000 USDT Prize Pool

PANAMA CITY, Feb. 14, 2026 /PRNewswire/ -- As global artificial intelligence capabilities continue to advance and Web3 infrastructure matures, AI…

2 months ago

BioRestorative Announces Closing of $5.0 Million Public Offering

MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage…

2 months ago

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

February 12, 2026 21:18 ET  | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus…

2 months ago